Cyanotech Corporation is engaged in the production of natural products derived from microalgae for the nutritional supplements market. The Company's products include Hawaiian Spirulina Pacifica and Hawaiian BioAstin. Hawaiian Spirulina Pacifica is a dietary supplement used for extra energy, a strengthened immune system, cardiovascular benefits and as a source of antioxidant carotenoids. Hawaiian BioAstin is a dietary antioxidant shown to support and maintain the body's natural inflammatory response, to enhance skin, and to support eye and joint health. The Company cultivates over two microalgal species from which its product lines, natural astaxanthin products and spirulina products, are derived. The Company produces its algae in Hawaii and manufactures the finished products in Hawaii and California.
Industry, Sector and Symbol:
- Industry: Biotechnology
- Sub-Industry: N/A
- Symbol: NASDAQ:CYAN
- CUSIP: N/A
- Web: www.cyanotech.com
- Market Cap: $20.12 million
- Outstanding Shares: 5,668,000
- 50 Day Moving Avg: $3.83
- 200 Day Moving Avg: $3.97
- 52 Week Range: $3.32 - $5.56
Sales & Book Value:
- Trailing P/E Ratio: N/A
- Foreward P/E Ratio: 8.88
- P/E Growth: 0.00
- Annual Revenue: $32.99 million
- Price / Sales: 0.61
- Book Value: $2.99 per share
- Price / Book: 1.19
- EBIDTA: $1.48 million
- Net Margins: -15.14%
- Return on Equity: -8.28%
- Return on Assets: -4.67%
- Debt-to-Equity Ratio: 0.38%
- Current Ratio: 2.02%
- Quick Ratio: 0.79%
- Average Volume: 1,766 shs.
- Beta: 1.53
- Short Ratio: 2.83
Frequently Asked Questions for Cyanotech Corp (NASDAQ:CYAN)
What is Cyanotech Corp's stock symbol?
Cyanotech Corp trades on the NASDAQ under the ticker symbol "CYAN."
How were Cyanotech Corp's earnings last quarter?
Cyanotech Corp (NASDAQ:CYAN) issued its quarterly earnings data on Tuesday, February, 7th. The company reported ($0.06) earnings per share for the quarter. The business had revenue of $7.61 million for the quarter. Cyanotech Corp had a negative net margin of 15.14% and a negative return on equity of 8.28%. View Cyanotech Corp's Earnings History.
When will Cyanotech Corp make its next earnings announcement?
Who are some of Cyanotech Corp's key competitors?
Some companies that are related to Cyanotech Corp include Trillium Therapeutics (TRIL), Histogenics Corp (HSGX), Chiasma (CHMA), Nivalis Therapeutics (NVLS), OHR Pharmaceutical (OHRP), KaloBios Pharmaceuticals (KBIO), Threshold Pharmaceuticals (THLD), Cytori Therapeutics (CYTX), Can Fite Biopharma Ltd (CANF), Alcobra Ltd (ADHD), Viking Therapeutics (VKTX), Mirna Therapeutics (MIRN), Ocera Therapeutics (OCRX), Catabasis Pharmaceuticals (CATB), Aldeyra Therapeutics (ALDX), Auris Medical Holding AG (EARS), Pain Therapeutics (PTIE) and Dimension Therapeutics (DMTX).
Who are Cyanotech Corp's key executives?
Cyanotech Corp's management team includes the folowing people:
- Michael A. Davis M.D., Independent Chairman of the Board
- Gerald R. Cysewski Ph.D., Interim President, Chief Executive Officer
- Jole Deal, Chief Financial Officer, Vice President - Finance and Administration, Treasurer, Secretary
- Gerard J. Watts, Chief Operating Officer
- James R. Lundeen, Vice President,Senior Strategist
- Nancy E. Katz, Director
- Walter B. Menzel, Independent Director
- David M. Mulder, Independent Director
- David L. Vied, Independent Director
How do I buy Cyanotech Corp stock?
Shares of Cyanotech Corp can be purchased through any online brokerage account. Popular online brokerages include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.
What is Cyanotech Corp's stock price today?
MarketBeat Community Rating for Cyanotech Corp (NASDAQ CYAN)MarketBeat's community ratings are surveys of what our community members think about Cyanotech Corp and other stocks. Vote "Outperform" if you believe the stock will outperform the S&P 500 over the long term. Vote "Underperform" if you believe the stock will underperform the S&P 500 over the long term. You may vote once every thirty days.
One share of Cyanotech Corp stock can currently be purchased for approximately $3.55.
Consensus Ratings for Cyanotech Corp (NASDAQ:CYAN) (?) The ratings breakdown includes the most recent rating from each analyst that has rated the stock within the last twelve months. The ratings score is a calculation of the average number of sell, hold, buy and strong buy ratings (0-1.5 = Sell, 1.5-2.5 = Hold, 2.5-3.5 = Buy, >3.5 = Strong Buy). The consensus price target is a mean average of the most recent price target set by each analyst that has set a price target for the stock in the last twelve months.
|Ratings Breakdown: ||No ratings tracked in the last 12 months.|
|Consensus Rating:||N/A (Score: NaN)|
|Consensus Price Target: ||N/A|
Analysts' Ratings History for Cyanotech Corp (NASDAQ:CYAN)
No equities research coverage for this company has been tracked by MarketBeat.com
Earnings History for Cyanotech Corp (NASDAQ:CYAN)Earnings History by Quarter for Cyanotech Corp (NASDAQ CYAN)
(Data available from 1/1/2011 forward)
|Date||Quarter||Consensus Estimate||Actual EPS||Revenue Estimate||Actual Revenue||Release Link||Conference Call||Details|
|6/21/2017|| || || || || || || || |
|2/7/2017||Q3 2017||($0.06)||$7.61 million||View||N/A|
|8/15/2016||Q117||($0.12)||$7.60 million||$7.32 million||View||N/A|
|8/7/2015||Q116||($0.02)||$7.62 million||$7.59 million||View||N/A|
|11/10/2014||Q215||$0.03||$7.30 million||$8.68 million||View||N/A|
|8/14/2014||Q115||($0.08)||$6.91 million||$7.44 million||View||N/A|
|2/6/2014||Q314||$0.01||$7.24 million||$7.44 million||View||N/A|
|11/7/2013||Q214||$0.02||$2.80 million||$3.00 million||View||N/A|
|8/12/2013||Q114||$0.01||$6.51 million||$6.91 million||View||N/A|
|6/24/2013||Q413||$0.47||$5.99 million||$6.90 million||View||N/A|
Earnings Estimates for Cyanotech Corp (NASDAQ:CYAN)
Current Year EPS Consensus Estimate: $-0.01 EPS
Next Year EPS Consensus Estimate: $0.40 EPS
Dividend History for Cyanotech Corp (NASDAQ:CYAN)
No dividend announcements for this company have been tracked by MarketBeat.com
Insider Trading and Institutional Ownership History for Cyanotech Corp (NASDAQ:CYAN)
Insider Ownership Percentage: 26.30%Insider Trades by Quarter for Cyanotech Corp (NASDAQ:CYAN)
Institutional Ownership Percentage: 14.82%
(Data available from 1/1/2013 forward)
|Transaction Date||Insider Name||Title||Buy/Sell||Number of Shares||Average Share Price||Total Transaction||Details|
|4/28/2016||Meridian Ohc Partners, Lp||Major Shareholder||Buy||7,910||$5.21||$41,211.10|| |
|4/27/2016||Meridian Ohc Partners, Lp||Major Shareholder||Buy||7,305||$5.19||$37,912.95|| |
|4/5/2016||Meridian Ohc Partners, Lp||Major Shareholder||Buy||5,542||$5.17||$28,652.14|| |
|3/23/2016||Meridian Ohc Partners, Lp||Major Shareholder||Buy||28,074||$5.05||$141,773.70|| |
|3/22/2016||Meridian Ohc Partners, Lp||Major Shareholder||Buy||2,112||$5.00||$10,560.00|| |
|3/21/2016||Meridian Ohc Partners, Lp||Major Shareholder||Buy||10,000||$5.06||$50,600.00|| |
|3/18/2016||Meridian Ohc Partners, Lp||Major Shareholder||Buy||40,514||$4.98||$201,759.72|| |
|3/4/2016||Meridian Ohc Partners, Lp||Major Shareholder||Buy||13,816||$4.68||$64,658.88|| |
|2/19/2014||Michael A / Davis||Director||Buy||50,000||$5.34||$267,000.00|| |
|12/7/2012||Michael A / Davis||Director||Buy||17,500||$5.01||$87,675.00|| |
Headline Trends for Cyanotech Corp (NASDAQ:CYAN)
Latest Headlines for Cyanotech Corp (NASDAQ:CYAN)
Cyanotech Corp (CYAN) Chart for Tuesday, May, 30, 2017